Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women

Circulation

Volumn 102, Issue 22, 2000, Pages 2687-2693

  Vehkavaara, S ^a   Hakala Ala Pietila, T ^a   Virkamaki, A ^a   Bergholm, R ^a   Ehnholm, C ^a   Hovatta, O ^a   Taskinen, M R ^a   Yki Jarvinen, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atherosclerosis; Blood flow; Endothelium

Indexed keywords

ACETYLCHOLINE; ESTRADIOL; ESTROFEM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034727702     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.22.2687     Document Type: Article

References (34)

1. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
3. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
4. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations
5. Biological effects of transdermal estradiol
6. A randomized comparison of nonoral estradiol delivery in postmenopausal women
7. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
8. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
9. Acute vascular effects of estrogen in postmenopausal women
10. Estrogen replacement reverses endothelial dysfunction in postmenopausal women
11. Estrogen therapy combined with progesterone and endothelium-dependent vasodilatation in postmenopausal women
12. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement
13. Treatment of hot flashes with transdermal estradiol administration
14. Minimization: A new method of assigning patients to treatment and control groups
15. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus
16. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes
17. Evaluation of radioimmunoassay for estradiol in unextracted serum
18. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor J, growth hormone and sex hormone binding globulin serum levels
19. Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma
20. Effects of hormonal treatment on plasma unbound androgen levels in hirsute women
21. Repeated measurements and multiple comparisons in cardiovascular research
22. Continuous, combined hormone replacement: Randomized comparison of transdermal and oral preparations
23. Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women
24. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
25. Vascular reactivity is impaired in genetic females taking high-dose androgens
26. Estrogen acutely increases peripheral blood flow in postmenopausal women
27. Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures
28. Efficacy of transdermal estradiol
29. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA
30. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial
31. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
32. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men
33. Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine
34. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women